Guidance for BioLife Solutions (BLFS)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2026 | N/A | N/A | $112.50M – 115.00M | $112.90M | = Maintained | Details |
| 2026 | N/A | N/A | $112.50M – 115.00M | $110.80M | = Maintained | Details |
| 2025 | N/A | N/A | $95.00M – 96.00M | $101.30M | = Maintained | Details |
| 2025 | N/A | N/A | $100.00M – 103.00M | $97.76M | = Maintained | Details |
| 2025 | N/A | N/A | $95.50M – 99.00M | $97.03M | = Maintained | Details |
| 2025 | N/A | N/A | $95.50M – 99.00M | $95.45M | = Maintained | Details |
| 2024 | N/A | N/A | $98.00M – 100.00M | $110.60M | = Maintained | Details |
| 2024 | N/A | N/A | $99.00M – 101.00M | $106.20M | = Maintained | Details |
| 2024 | N/A | N/A | $95.50M – 100.00M | $106.30M | = Maintained | Details |
| 2023 | N/A | N/A | $144.00M – 158.00M | $184.10M | = Maintained | Details |
| 2022 | N/A | N/A | $160.00M – 164.00M | $163.40M | = Maintained | Details |
| 2022 | N/A | N/A | $159.50M – 171.00M | N/A | = Maintained | Details |
| 2022 | N/A | N/A | $159.50M – 171.00M | N/A | = Maintained | Details |
| 2021 | N/A | N/A | $115.00M – 119.00M | $114.40M | = Maintained | Details |
| 2021 | N/A | N/A | $108.00M – 117.00M | $110.00M | = Maintained | Details |
| 2020 | N/A | N/A | $48.00M – 53.00M | $52.35M | = Maintained | Details |
| 2019 | N/A | N/A | $50.00M – 56.00M | $28.72M | = Maintained | Details |
| 2019 | N/A | N/A | $27.00M – 30.00M | $28.70M | = Maintained | Details |
| Q1 2019 | N/A | N/A | $27.00M – 30.00M | $28.04M | = Maintained | Details |
| 2018 | N/A | ($0.01) | $18.50M – 20.00M | $15.37M | = Maintained | Details |
| Q2 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q4 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q3 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q2 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q1 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
